The cardiovascular continuum from the hypertensive state to decompensated heart failure has seen in the last decade a great improvement not only in pharmacological therapy but also in the device-based treatment. This aspect is particularly evident for the great development of devices useful to improve contractility and hemodynamic of the heart and for the important evolution in left ventricular assist devices. In hypertensive patients, the evolution has been concentrated on devices capable of interfering with the pathophysiologic mechanisms that sustain blood pressure, i.e., adrenergic tone and baroreflex mechanism. The chapter will briefly depict the principal innovative devices developed for treating these pathophysiologic conditions.
Seravalle, G., Grassi, G. (2023). Device-Based Treatment in Hypertension and Heart Failure. In V.C. Dorubantu M (a cura di), Hypertension and Heart Failure Epidemiology, Mechanisms and Treatment (pp. 423-437). Springer international Publishing [10.1007/978-3-031-39315-0_27].
Device-Based Treatment in Hypertension and Heart Failure
Gino, Seravalle;Grassi, Guido
2023
Abstract
The cardiovascular continuum from the hypertensive state to decompensated heart failure has seen in the last decade a great improvement not only in pharmacological therapy but also in the device-based treatment. This aspect is particularly evident for the great development of devices useful to improve contractility and hemodynamic of the heart and for the important evolution in left ventricular assist devices. In hypertensive patients, the evolution has been concentrated on devices capable of interfering with the pathophysiologic mechanisms that sustain blood pressure, i.e., adrenergic tone and baroreflex mechanism. The chapter will briefly depict the principal innovative devices developed for treating these pathophysiologic conditions.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
